Product Information
PODOFILOX 0.5% GEL is a generic product labeled by Padagis US LLC, priced at $129.9855 per GM under NDC 00574062105. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Nov 22, 2023.
Strength
5 mg/g
Manufacturer
Padagis US LLCNDC
00574062105
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
PODOFILOXApproval Type
Generic (ANDA)
FDA Application
ANDA211871FDA Approved
11/22/2023
On Market Since
12/13/2023
Pharmacological Classes
Price Statistics
The NADAC for PODOFILOX 0.5% GEL has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $129.9855 per GM |
|---|---|
| All-time high | $136.6320 (Nov 12, 2025) |
| All-time low | $95.4189 (Jul 17, 2024) |
| 52-week high | $136.6320 |
| 52-week low | $124.0886 |
| Median price | $126.0115 |
| Average price | $122.5608 |
| Largest weekly change | +20.6% (Nov 13, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Podofilox market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Podofilox market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PODOFILOX 0.5% GEL?
The current National Average Drug Acquisition Cost (NADAC) for PODOFILOX 0.5% GEL, manufactured by Padagis US LLC, is $129.9855 per GM (NDC 00574062105), effective Sep 30, 2026.
How has the price of PODOFILOX 0.5% GEL changed over time?
Over the history we have for it, the NADAC for PODOFILOX 0.5% GEL has risen 20.3%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for PODOFILOX 0.5% GEL?
Since Apr 17, 2024, the NADAC for PODOFILOX 0.5% GEL has ranged from a low of $95.4189 (Jul 17, 2024) to a high of $136.6320 (Nov 12, 2025), with a median of $126.0115 per GM.
Are there cheaper alternatives to PODOFILOX 0.5% GEL?
No other NADAC-published product currently shares the active ingredient and strength of PODOFILOX 0.5% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PODOFILOX 0.5% GEL?
PODOFILOX 0.5% GEL (NDC 00574062105) is labeled by Padagis US LLC, and CMS classifies it as a generic product.